Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 14, 2023
Patent Application Number
17662766
Date Filed
May 10, 2022
Patent Citations
Patent Primary Examiner
CPC Code
The disclosure provides immune cells comprising a first activator receptor specific to mesothelin and a second inhibitory receptor specific to a ligand that has been lost in a mesothelin-positive cancer cell, and methods of making and using same for the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
